Oxford / Manchester / Nottingham / Glick / Rockville / New York / Washington / DC / Cambridge / Calgary / London / Chicago / Glanville / /
Company
SPSS Inc / Eli Lilly / Awad AG / FGA / SGA / No. (%) White Black / Bristol Myers Squibb / Cochrane Review / Lehman / Pearson / Other Diagnosis / StataCorp / No. (%) M F Ethnicity / Youle S / John Wiley & Sons / evaluated using Pearson / /
Country
United Kingdom / United States / /
Currency
GBP / USD / / /
Event
Product Issues / Product Recall / /
Facility
University of Manchester / Arch Gen Psychiatry / Imperial College / Center Research Ethics Committee / National Institute / University Of Arizona / College Station / Cochrane Library / Addenbrooke’s Hospital / University of Cambridge / Institute of Psychiatry / ARCH GEN PSYCHIATRY/ VOL / Stanley Medical Research Institute / depot FGAs / /
IndustryTerm
pharmaceutical industry / drug management / treatment of negative symptoms / community psychiatric services / outpatient services / remote telephone service / community care services / social network / social care services / /
MedicalCondition
fairly long-term illness / wk Calgary depression / severe and persistent mental disorders / schizoaffective disorder / related psychoses / Severe Mental Disorders / neuroleptic malignant syndrome / illness / schizophrenic deficit syndrome / schizophrenia / parkinsonism / diabetes / septicemia / delusional disorder vs schizophrenia / resistant schizophrenia / medical disorder / cardiac failure / DSM-IV10 schizophrenia / observed akathisia and improved cognition / obesity / MS / chronic schizophrenia / Refractory Schizophrenia / Mental Disorders / DSM-IV schizophrenia / delusional disorder / related disorders / chronic mental illness / Schissel B. A depression / treatmentresistant schizophrenia / /
Department of Psychiatry / Addenbrooke’s Hospital / Stanley Medical Research Institute / University of Cambridge and Cambridgeshire / American Psychiatric Association / Institute of Psychiatry / Division of Neurosciences and Mental Health / National Collaborating Centre for Mental Health / University of Manchester / Manchester / North West Multi-Center Research Ethics Committee / Department of Veterans Affairs / Imperial College / English National Health Service / American Diabetes Association / American Association of Clinical Endocrinologists / United Kingdom National Health Service / University of Cambridge / North American Association for the Study of Obesity / American Medical Association / University of Arizona / National Institute for Clinical Excellence / /
Person
Robin M. Murray / Kay SR / Karen P. Hayhurst / Alison Markwick / Linda Davies / Thomas R. E. Barnes / Helen Lloyd / Awad A. Comparative / Graham Dunn / Peter B. Jones / W. ECDEU / /
Position
psychiatrist / referring psychiatrist / managing psychiatrist / General / Secretary of State / Author / consultant / Carpenter / /
ORIGINAL ARTICLE Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CU